<DOC>
<DOCNO>
EP-0004059
</DOCNO>
<TEXT>
<DATE>
19790919
</DATE>
<IPC-CLASSIFICATIONS>
A61K-31/415 C07D-233/00 C07D-233/38 <main>C07D-233/38</main> 
</IPC-CLASSIFICATIONS>
<TITLE>
synthesis of 1-(thiocarbamoyl)-2-imidazolidinone and immunosuppressive compositions containing it.
</TITLE>
<APPLICANT>
univ case western reserveus <sep>univ northwesternus <sep>case western reserve university <sep>northwestern university<sep>case western reserve university2040 adelbert roadcleveland ohio 44106us<sep>northwestern universityrebecca crown centerevanston illinois 60201us<sep>case western reserve university<sep>northwestern university<sep>
</APPLICANT>
<INVENTOR>
warren kenneth s<sep>webster leslie t c o school of<sep>warren, kenneth s.<sep>webster, leslie t. c/o school of medicine<sep>warren, kenneth s.rockefeller foundation 1133 avenue of the americasnew york new york 10036us<sep>webster, leslie t. c/o school of medicinedept. of pharmacology case western reserve univ.cleveland, ohio 44106us<sep>warren, kenneth s. <sep>webster, leslie t. c/o school of medicine<sep>warren, kenneth s. rockefeller foundation 1133 avenue of the americas new york new york 10036 us<sep>webster, leslie t. c/o school of medicinedept. of pharmacology case western reserve univ.cleveland, ohio 44106us<sep>
</INVENTOR>
<ABSTRACT>
an immunosuppressive composition of matter comprising  a pharmacologically acceptable diluent and an  immunosuppressive effective amount of synthetically produced  1-(thiocarbamoyl)-2-imidazolidinone of the formula    the method of suppressing an immunological response in a  patient by administering an immunosuppressive effective  amount of synthetically produced 1-(thiocarbamoyl)-2-imidazolidinone  and a process for preparing  1-(thiocarbamoyl)-2-imidazolidinone.  
</ABSTRACT>
</TEXT>
</DOC>
